CBDHF - InvestorNewsBreaks - HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Appoints Current VP Controller as Interim CFO
HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness company offering premium probiotic supplements and products containing CBD, announced the appointment of an interim chief financial officer; the company named Maria Leal, who is currently serving as both controller and company vice president, to the position. A CPA and MBA, Leal has built a strong reputation for strong financial management over the past two decades. She has served in a variety of financial accounting roles and landed at HempFusion in 2019. Management noted that Leal has been instrumental in all financial reporting aspects for the company since joining the company. Leal replaces Bruce Valentine, who served as chief financial officers before Leal, is resigning because of the unexpected death of his mother and the resulting duties that have arisen. “On behalf of the company and the employees of HempFusion, we send our deepest condolences to Bruce and his family for their loss,” said HempFusion CEO Jason Mitchell, ND, in the press release. “I would like to thank Bruce for his contributions to the company. The Board has begun a process to appoint a successor to Mr. Valentine and a further announcement will be made in due course. In the meantime, the board has full confidence that Ms. Leal will succeed in shepherding HempFusion’s finance and accounting functions. She has been an integral part of the development and implementation of the financial planning and accounting functions over the past several years.”
To view the full press release, visit https://ibn.fm/9bYRu
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in stores or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at http://ibn.fm/HempFusion
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.